IP Library Granted Patent US 8,417,320
Granted Patent B2
US 8,417,320 · App. 13/133,290 · Granted Apr 9, 2013

Syringe with visual use indicator

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,417,320
App. No.
13/133,290
Granted
Apr 9, 2013
Kind
B2
Abstract

Systems and methods are presented for the visual indication of whether a power injector has discharged fluid from a power injector syringe in a previous medical procedure. In this regard, the systems and methods generally provide for a power injector and a syringe for use with the power injector. The syringe includes a visual indicator ( 164 ) that moves between a first state and a second state at approximately the same time that the power injector discharges fluid from the syringe such that an operator may view the change in state.

Claims (33)

1. A power injector comprising:

a syringe plunger driver comprising a motorized drive source and a plunger interface, wherein said plunger interface is movable in multiple directions by operation of said motorized drive source; and

a syringe comprising an internal fluid discharge chamber, a syringe plunger movably disposed within said fluid discharge chamber, and a visual indicator member disposed outside of said internal fluid discharge chamber, wherein said syringe plunger driver interacts with said syringe plunger to move said syringe plunger in at least a first direction, wherein said visual indicator member is in a first state prior to movement of said syringe plunger by said syringe plunger driver, and wherein said visual indicator member is irreversibly changed to a second state in response to movement of said syringe plunger by said syringe plunger driver and a resulting pressurization within said internal fluid discharge chamber.

2. The power injector of claim 1 , wherein said syringe plunger driver comprises an axially movable ram that comprises said plunger interface.

3. The power injector of claim 1 , wherein said visual indicator member at all times remains fluidly isolated from said internal fluid discharge chamber of said syringe.

4. The power injector of claim 1 , wherein said syringe comprises a syringe body, wherein said syringe plunger is movably disposed within said syringe body, and wherein said visual indicator member interfaces with an exterior of said syringe body.

5. The power injector of claim 1 , further comprising a label attached to said syringe, wherein said visual indicator member is disposed between said label and an exterior of said syringe.

6. The power injector of claim 1 , wherein said visual indicator member comprises a pressure-sensitive material.

7. The power injector of claim 6 , wherein said first state for said pressure-sensitive material is a first color, and wherein said second state for said pressure-sensitive material is a second color.

8. The power injector of claim 6 , further comprising a label attached to said syringe, wherein said label comprises at least one transparent section coinciding with said pressure-sensitive material.

9. The power injector of claim 1 , wherein said visual indicator member comprises a fluid source.

10. The power injector of claim 9 , wherein said fluid source comprises an enclosure and a first fluid within said enclosure.

11. The power injector of claim 10 , wherein said first fluid comprises a colored liquid.

12. The power injector of claim 10 , wherein said enclosure is a deformable member.

13. The power injector of claim 12 , wherein said enclosure ruptures upon exposure to at least a certain pressure.

14. The power injector of claim 10 , wherein said enclosure comprises a blister pack.

15. The power injector of claim 10 , wherein said visual indicator member further comprises a flowpath fluidly interconnectable with said fluid source.

16. The power injector of claim 15 , wherein said fluid source and said flowpath are fluidly isolated when said visual indicator member is in said first state, and wherein said fluid source communicates with said flowpath when said visual indicator member is in said second state.

17. The power injector of claim 16 , wherein said syringe comprises a syringe body, wherein an exterior of said syringe body comprises a channel, and wherein said channel comprises said flowpath.

18. The power injector of claim 17 , wherein said channel extends at least about 10% of a length of said syringe body.

19. The power injector of claim 17 , further comprising a label disposed over said channel.

20. The power injector claim 9 , wherein said syringe comprises a movable member aligned with said fluid source.

21. The power injector of claim 20 , wherein said movable member moves from a first position to a second position in response to a differential pressure that develops by advancement of said syringe plunger.

22. The power injector of claim 21 , wherein fluid is released from said fluid source in response to said movable member moving from said first position to said second position.

23. The power injector of claim 20 , wherein said movable member comprises a dimple.

24. The power injector of claim 23 , wherein said dimple inverts in response to movement of said syringe plunger.

25. The power injector of claim 23 , wherein said dimple is convex on an interior of said syringe and is concave on an exterior of said syringe prior to movement of said syringe plunger in a direction to discharge fluid from said syringe.

26. The power injector of claim 25 , wherein movement of said syringe plunger in a direction to discharge fluid from said syringe inverts said dimple so that said dimple is concave on said interior of said syringe and is convex on said exterior of said syringe.

27. The power injector of claim 23 , wherein inversion of said dimple in response to movement of said syringe plunger ruptures said fluid source.

28. The power injector of claim 20 , wherein said movable member comprises a deformable section of said syringe.

29. The power injector of claim 9 , wherein said syringe comprises a syringe body, that in turn comprises a barrel and a discharge port, wherein said fluid source is located between said syringe barrel and said discharge port.

30. The power injector of claim 9 , further comprising a pressure jacket, wherein said syringe is disposed within said pressure jacket, wherein said syringe comprises a frustumly-shaped surface, and wherein said fluid source is disposed between said frustumly-shaped surface of said syringe and said pressure jacket.

31. The power injector of claim 9 , wherein said fluid source comprises a colored liquid.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2011
From: MARTZ, KEVIN R.
To: MALLINCKRODT INC.
Reel/Frame 026403/0061 →